講演情報
[P081]Evaluation of Intradermal Injection System (Terumo) for the Live Attenuated Vaccine, centrin-deficient Leishmania major (LmCen-/-), against Leishmaniasis
○Farzaneh Valanezhad1, Jalal Alshaweesh2, Shara Bakytbek1, Sakiko Shimizu3, Ryo Tanaka3, Yoichiro Iwase3, Risa Nakamura1, Greg Matlashewski4, Sreenivas Gannavaram5, Hira Nakhasi5, Abhay Satoskar6, Shinjiro Hamano1 (1. 1-Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki, Japan (Japan), 2. 4-The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Japan (Japan), 3. 5-TERUMO Corporation, Medical Care Solutions Company, Pharmaceutical Solutions Division, R&D, Japan (Japan), 4. 6-Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada (Canada), 5. 7-Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 US (United States of America), 6. 8-Department of Pathology, The Ohio State University, Columbus, Ohio, US (United States of America))
閲覧にはパスワードが必要です
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン